27 November 2020 | NewsCOVID-19 vaccines: Frequently asked questionsRead the full article
The BCG vaccination to Reduce the impact of COVID-19 in healthcare workers following Coronavirus Exposure (BRACE) trial was launched by Murdoch Children’s Research Institute (MCRI). The clinical trials teams at NCIRS and Kids Research, Sydney Children’s Hospital Network will be coordinating the trial in NSW with the other sites across Sydney that will be involved, including Westmead Hospital, Sydney Children’s Hospital Randwick, Prince of Wales Hospital and St Vincent’s Hospital.
Healthcare workers are at increased risk of contracting COVID-19, caused by SARS-CoV-2. Currently, there are no vaccines or proven preventative interventions available to protect healthcare workers.
The BCG vaccine is one of the most widely used vaccines in the world, given to over 130 million babies worldwide each year. In addition to preventing tuberculosis, this vaccine also boosts immunity against a variety of other infections.
The purpose of the BRACE trial is to find out whether BCG vaccination protects against COVID-19 or reduces severity of COVID-19 in Australian healthcare workers.
In total, the randomised controlled trial will test 10,000 healthcare workers across Australia, and other countries, including the Netherlands and Spain. Half of the participants will receive the BCG vaccine while the other half will receive a placebo. Participants will then be tracked over a period of 12 months to record if they contract COVID-19 and the severity of their symptoms.
Recruiting healthcare workers (Visit the MCRI website for more information to register to participate in the trial.)
NCIRS, Kids Research, Sydney Children’s Hospitals Network, Cnr Hawkesbury Rd & Hainsworth St, Westmead Locked Bag 4001, Westmead NSW 2145 Tel (612) 9845 1433 | Fax (612) 9845 1418 | ABN 53 188 579 090
We acknowledge that the National Centre for Immunisation Research and Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.
Copyright © 2021 NCIRS. All rights reserved
Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.
Stay updated with the latest from NCIRS